Published in Nat Genet on March 01, 1998
Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest (2002) 5.83
Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Invest (2000) 3.00
Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor. N Engl J Med (2007) 2.56
The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest (2003) 2.42
Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults. Proc Natl Acad Sci U S A (2004) 2.41
Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. J Leukoc Biol (2008) 2.34
Recent advances in understanding leptin signaling and leptin resistance. Am J Physiol Endocrinol Metab (2009) 2.27
Adipose tissue: the new endocrine organ? A review article. Dig Dis Sci (2008) 2.26
The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr Rev (2010) 2.09
Narrative review: the role of leptin in human physiology: emerging clinical applications. Ann Intern Med (2010) 2.00
Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab (2011) 1.99
The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol (2009) 1.81
Changes in insulin sensitivity during leptin replacement therapy in leptin-deficient patients. Am J Physiol Endocrinol Metab (2008) 1.60
Lack of support for the association between GAD2 polymorphisms and severe human obesity. PLoS Biol (2005) 1.59
Genome scan for human obesity and linkage to markers in 20q13. Am J Hum Genet (1999) 1.58
Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. J Clin Invest (2004) 1.55
Genetic approaches to understanding human obesity. J Clin Invest (2011) 1.50
From monogenic to polygenic obesity: recent advances. Eur Child Adolesc Psychiatry (2010) 1.49
Leptin in human physiology and therapeutics. Front Neuroendocrinol (2010) 1.46
Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microb Cell Fact (2011) 1.45
Call for action: preventing and managing the expansive and expensive obesity epidemic. CMAJ (1999) 1.39
From obesity genetics to the future of personalized obesity therapy. Nat Rev Endocrinol (2013) 1.29
Leptin replacement improves cognitive development. PLoS One (2008) 1.27
Common variants in the 5' region of the leptin gene are associated with body mass index in men from the National Heart, Lung, and Blood Institute Family Heart Study. Am J Hum Genet (2004) 1.27
Pediatric obesity: etiology and treatment. Endocrinol Metab Clin North Am (2009) 1.22
Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol (2013) 1.21
Recent advances in the genetics of severe childhood obesity. Arch Dis Child (2000) 1.21
Leptin restores adult hippocampal neurogenesis in a chronic unpredictable stress model of depression and reverses glucocorticoid-induced inhibition of GSK-3β/β-catenin signaling. Mol Psychiatry (2011) 1.20
Genetics of obesity. Philos Trans R Soc Lond B Biol Sci (2006) 1.19
Leptin and Inflammation. Curr Immunol Rev (2008) 1.19
A rare variant of the leptin gene has large effects on blood pressure and carotid intima-medial thickness: a study of 1428 individuals in 248 families. J Med Genet (2005) 1.16
Phenotypic and genetic variation in leptin as determinants of weight regain. Int J Obes (Lond) (2010) 1.14
Effects of mutations in the human uncoupling protein 3 gene on the respiratory quotient and fat oxidation in severe obesity and type 2 diabetes. J Clin Invest (1998) 1.12
Human gene mutations causing infertility. J Med Genet (2002) 1.12
Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev (2013) 1.10
Leptin signaling and leptin resistance. Front Med (2013) 1.08
Abnormal regulation of the leptin gene in the pathogenesis of obesity. Proc Natl Acad Sci U S A (1998) 1.05
Effects of leptin and melanocortin signaling interactions on pubertal development and reproduction. Endocrinology (2012) 1.03
Leptin: at the crossroads of energy balance and systemic inflammation. Prog Lipid Res (2006) 1.02
Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression. Transl Psychiatry (2012) 1.02
The role of leptin in innate and adaptive immune responses. Arthritis Res Ther (2006) 0.99
The somatotrope as a metabolic sensor: deletion of leptin receptors causes obesity. Endocrinology (2010) 0.99
Recent advances in obesity: genetics and beyond. ISRN Endocrinol (2012) 0.98
Functional consequences of the human leptin receptor (LEPR) Q223R transversion. Obesity (Silver Spring) (2008) 0.96
Central overexpression of leptin antagonist reduces wheel running and underscores importance of endogenous leptin receptor activity in energy homeostasis. Am J Physiol Regul Integr Comp Physiol (2009) 0.95
The ventral premammillary nucleus links metabolic cues and reproduction. Front Endocrinol (Lausanne) (2011) 0.95
The role of leptin in regulating bone metabolism. Metabolism (2014) 0.95
The genetic basis of female reproductive disorders: etiology and clinical testing. Mol Cell Endocrinol (2013) 0.94
Deciphering genetic disease in the genomic era: the model of GnRH deficiency. Sci Transl Med (2010) 0.94
Body weight impact on puberty: effects of high-calorie diet on puberty onset in female rhesus monkeys. Endocrinology (2012) 0.94
Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy. Arq Bras Endocrinol Metabol (2010) 0.94
Monogenic forms of childhood obesity due to mutations in the leptin gene. Mol Cell Pediatr (2014) 0.93
Metabolic risk susceptibility in men is partially related to adiponectin/leptin ratio. J Obes (2013) 0.92
Pharmacogenetics of antipsychotic-induced weight gain. Psychopharmacology (Berl) (2004) 0.92
Analysis of sequence variations in the suppressor of cytokine signaling (SOCS)-3 gene in extremely obese children and adolescents. BMC Med Genet (2007) 0.92
The neuropathology of obesity: insights from human disease. Acta Neuropathol (2013) 0.91
Effects of leptin on intake of specific micro- and macronutrients in a woman with leptin gene deficiency studied off and on leptin at stable body weight. Appetite (2007) 0.91
Leptin and leptin receptor: analysis of a structure to function relationship in interaction and evolution from humans to fish. Peptides (2012) 0.91
Genetics of isolated hypogonadotropic hypogonadism: role of GnRH receptor and other genes. Int J Endocrinol (2011) 0.91
Obesity and lipodystrophy--where do the circles intersect? Endocrinology (2008) 0.91
Caloric restriction: impact upon pituitary function and reproduction. Ageing Res Rev (2008) 0.91
Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective. Mol Genet Genomics (2015) 0.90
Leptin as a modulator of neuroendocrine function in humans. Yonsei Med J (2012) 0.90
Endocrine dysregulation in anorexia nervosa update. J Clin Endocrinol Metab (2011) 0.90
Human adipose dynamics and metabolic health. Ann N Y Acad Sci (2013) 0.90
The role of leptin in glucose homeostasis. J Diabetes Investig (2012) 0.90
Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol (2011) 0.89
Genome-wide meta-analysis uncovers novel loci influencing circulating leptin levels. Nat Commun (2016) 0.88
Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone (2009) 0.87
Gender-specific metabolomic profiling of obesity in leptin-deficient ob/ob mice by 1H NMR spectroscopy. PLoS One (2013) 0.87
Towards a serotonin-dependent leptin roadmap in the brain. Trends Endocrinol Metab (2011) 0.87
A potential mechanism for the sexual dimorphism in the onset of puberty and incidence of idiopathic central precocious puberty in children: sex-specific kisspeptin as an integrator of puberty signals. Front Endocrinol (Lausanne) (2012) 0.87
Implications of gene-behavior interactions: prevention and intervention for obesity. Obesity (Silver Spring) (2008) 0.86
New pharmacological perspectives for the leptin receptor in the treatment of obesity. Front Endocrinol (Lausanne) (2014) 0.86
Association of ghrelin and leptin with reproductive hormones in constitutional delay of growth and puberty. Reprod Biol Endocrinol (2010) 0.86
Beyond Leptin: Emerging Candidates for the Integration of Metabolic and Reproductive Function during Negative Energy Balance. Front Endocrinol (Lausanne) (2011) 0.84
Leptin and puberty. Arch Dis Child (2000) 0.84
The unique cysteine knot regulates the pleotropic hormone leptin. PLoS One (2012) 0.84
ENU mutagenesis identifies mice with morbid obesity and severe hyperinsulinemia caused by a novel mutation in leptin. PLoS One (2010) 0.84
Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C. Can J Gastroenterol (2007) 0.84
Leptin and its associations with measures of psychopathology in patients with anorexia nervosa. J Neural Transm (Vienna) (2008) 0.83
Whole-exome sequencing identifies novel LEPR mutations in individuals with severe early onset obesity. Obesity (Silver Spring) (2013) 0.83
Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Appl Environ Microbiol (2007) 0.82
An overview of mongenic and syndromic obesities in humans. Pediatr Blood Cancer (2011) 0.82
acp Best Practice No 168. The investigation and management of obesity. J Clin Pathol (2003) 0.82
Leptin applications in 2015: what have we learned about leptin and obesity? Curr Opin Endocrinol Diabetes Obes (2015) 0.82
Genetic variation at selected SNPs in the leptin gene and association of alleles with markers of kidney disease in a Xhosa population of South Africa. PLoS One (2010) 0.81
Discovering Genes Essential to the Hypothalamic Regulation of Human Reproduction Using a Human Disease Model: Adjusting to Life in the "-Omics" Era. Endocr Rev (2015) 0.81
Leptin in pediatrics: A hormone from adipocyte that wheels several functions in children. Indian J Endocrinol Metab (2012) 0.81
Endocrine effects of anorexia nervosa. Endocrinol Metab Clin North Am (2013) 0.81
A novel mutation in leptin gene is associated with severe obesity in Chinese individuals. Biomed Res Int (2014) 0.81
Leptin therapy, insulin sensitivity, and glucose homeostasis. Indian J Endocrinol Metab (2012) 0.81
Pediatric obesity. An introduction. Appetite (2015) 0.81
Obesity and the ageing brain: could leptin play a role in neurodegeneration? Curr Gerontol Geriatr Res (2011) 0.80
Genetic association study of selected candidate genes (ApoB, LPL, Leptin) and telomere length in obese and hypertensive individuals. BMC Med Genet (2009) 0.80
Evidence for positive selection on the leptin gene in Cetacea and Pinnipedia. PLoS One (2011) 0.80
Leptin increases L-type Ca2+ channel expression and GnRH-stimulated LH release in LbetaT2 gonadotropes. Mol Cell Endocrinol (2008) 0.79
Selective deletion of leptin receptors in gonadotropes reveals activin and GnRH-binding sites as leptin targets in support of fertility. Endocrinology (2014) 0.79
Neuroendocrine causes of amenorrhea--an update. J Clin Endocrinol Metab (2015) 0.79
A nonsense loss-of-function mutation in PCSK1 contributes to dominantly inherited human obesity. Int J Obes (Lond) (2014) 0.79
Molecular characterization of the human beta 3-adrenergic receptor. Science (1989) 4.13
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest (1999) 3.19
Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry (2006) 2.77
Tissue distribution of beta 3-adrenergic receptor mRNA in man. J Clin Invest (1993) 2.16
Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the beta 3-adrenergic-receptor gene. N Engl J Med (1995) 1.99
Role of transforming growth factor beta type II receptor in hepatic fibrosis: studies of human chronic hepatitis C and experimental fibrosis in rats. Hepatology (1999) 1.90
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med (1995) 1.88
Complete amino acid sequence and maturation of the mouse submaxillary gland renin precursor. Nature (1982) 1.83
Anti-alprenolol anti-idiotypic antibodies bind to beta-adrenergic receptors and modulate catecholamine-sensitive adenylate cyclase. Proc Natl Acad Sci U S A (1980) 1.80
A common polymorphism in the promoter of UCP2 is associated with decreased risk of obesity in middle-aged humans. Nat Genet (2001) 1.79
A rabbit with the allotypic phenotype: ala2a3 b4b5b6. J Immunol (1974) 1.77
The human beta 3-adrenoceptor: the search for a physiological function. Trends Pharmacol Sci (1994) 1.76
Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol Cell Endocrinol (2001) 1.75
Internalization of beta-adrenergic receptor in A431 cells involves non-coated vesicles. Eur J Cell Biol (1989) 1.71
Molecular characterization of the mouse beta 3-adrenergic receptor: relationship with the atypical receptor of adipocytes. EMBO J (1991) 1.65
Structure of the gene for human beta 2-adrenergic receptor: expression and promoter characterization. Proc Natl Acad Sci U S A (1987) 1.62
ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol (1998) 1.56
Regulation of gamma-glutamyl transpeptidase and alkaline phosphatase activities in immortalized rat brain microvessel endothelial cells. J Cell Physiol (1994) 1.55
Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem (1994) 1.46
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1990) 1.44
Synchronicity of frequently sampled thyrotropin (TSH) and leptin concentrations in healthy adults and leptin-deficient subjects: evidence for possible partial TSH regulation by leptin in humans. J Clin Endocrinol Metab (2001) 1.38
Evidence for reversible microclustering of lentil lectin membrane receptors on HeLa cells. FEBS Lett (1980) 1.34
The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Mol Pharmacol (1993) 1.31
Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemic control. Clin Biochem (2001) 1.28
Evidence for a functional beta 3-adrenoceptor in man. Br J Pharmacol (1993) 1.27
Effect of anesthesia on glucose production and utilization in rats. Am J Physiol (1987) 1.27
The human carcinoma cell line A431 possesses large numbers of functional beta-adrenergic receptors. FEBS Lett (1984) 1.25
A neuronal nitric oxide synthase (NOS-I) haplotype associated with schizophrenia modifies prefrontal cortex function. Mol Psychiatry (2006) 1.24
Comparison of the N-terminal sequences of aspartate and ornithine carbamoyltransferases of Escherichia coli. FEBS Lett (1977) 1.23
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J (1997) 1.22
Nitric oxide and endothelin secretion by brain microvessel endothelial cells: regulation by cyclic nucleotides. J Cell Physiol (1993) 1.20
Atypical beta-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human beta 3-adrenergic receptor. J Biol Chem (1991) 1.19
"Antibodies raised against beta-adrenergic receptors stimulate adenylate cyclase". Biochem Biophys Res Commun (1981) 1.18
Genetic variation in the stress protein hsp70-2 gene is highly associated with obesity. Int J Obes Relat Metab Disord (2001) 1.17
Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor. Mol Pharmacol (1993) 1.17
Extensive sequence homologies among lectins from leguminous plants. Biochem Biophys Res Commun (1977) 1.17
Leptin receptor gene variation and obesity: lack of association in a white British male population. Hum Mol Genet (1997) 1.16
Mediation of most atypical effects by species homologues of the beta 3-adrenoceptor. Br J Pharmacol (1994) 1.15
Molecular characterization of salt-stress-associated protein in citrus: protein and cDNA sequence homology to mammalian glutathione peroxidases. Plant Mol Biol (1993) 1.15
The effect of stromelysin-1 (MMP-3) on non-collagenous extracellular matrix proteins of demineralized dentin and the adhesive properties of restorative resins. Biomaterials (2008) 1.15
Hypoxia increases leptin expression in human PAZ6 adipose cells. Diabetologia (2002) 1.14
Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines. J Pharmacol Exp Ther (1994) 1.14
Isolation of adenylate cyclase-free, beta-adrenergic receptor from turkey erythrocyte membranes by affinity chromatography. Proc Natl Acad Sci U S A (1977) 1.13
Characterization, serological specificity, and diagnostic possibilities of monoclonal antibodies against Legionella pneumophila. J Clin Microbiol (1983) 1.12
Substituting selenocysteine for catalytic cysteine 41 enhances enzymatic activity of plant phospholipid hydroperoxide glutathione peroxidase expressed in Escherichia coli. J Biol Chem (2000) 1.12
beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody. Proc Natl Acad Sci U S A (1985) 1.11
Evidence for essential disulfide bonds in beta1-adrenergic receptors of turkey erythrocyte membranes. Inactivation by dithiothreitol. J Biol Chem (1979) 1.10
A functional dopamine-beta-hydroxylase gene promoter polymorphism is associated with impulsive personality styles, but not with affective disorders. J Neural Transm (Vienna) (2008) 1.10
Dual signaling of human Mel1a melatonin receptors via G(i2), G(i3), and G(q/11) proteins. Mol Endocrinol (1999) 1.09
The production and characterization of antibodies against beta-adrenergic antagonists. Biochem Pharmacol (1978) 1.09
The effects of gonadotropin treatment on the immunological features of male patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab (2000) 1.08
Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Mol Cell Endocrinol (2006) 1.08
Functional expression of the human serotonin 5-HT1A receptor in Escherichia coli. Ligand binding properties and interaction with recombinant G protein alpha-subunits. J Biol Chem (1992) 1.08
Antigenic analysis of the second extra-cellular loop of the human beta-adrenergic receptors. Clin Exp Immunol (1989) 1.07
Redistribution of muscarinic acetylcholine receptors on human fibroblasts induced by regulatory ligands. Biol Cell (1987) 1.06
Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway. Biochem Pharmacol (1999) 1.06
Human beta 2-adrenergic receptors expressed in Escherichia coli membranes retain their pharmacological properties. Proc Natl Acad Sci U S A (1988) 1.05
Effector-dependent conformational changes in protein kinase C gamma through epitope mapping with inhibitory monoclonal antibodies. Eur J Biochem (1990) 1.05
Expression of three human beta-adrenergic-receptor subtypes in transfected Chinese hamster ovary cells. Eur J Biochem (1991) 1.05
New molecular and structural determinants involved in beta 2-adrenergic receptor desensitization and sequestration. Delineation using chimeric beta 3/beta 2-adrenergic receptors. J Biol Chem (1996) 1.04
Molecular basis of insulin action. Diabetes Metab (1998) 1.04
The leptin receptor promoter controls expression of a second distinct protein. Nucleic Acids Res (1997) 1.04
Localisation of three epitopes of the env protein of feline immunodeficiency virus. Mol Immunol (1992) 1.03
Stimulation of the extracellular signal-regulated kinase 1/2 pathway by human beta-3 adrenergic receptor: new pharmacological profile and mechanism of activation. Mol Pharmacol (1999) 1.03
Serotonin transporter gene variation impacts innate fear processing: Acoustic startle response and emotional startle. Mol Psychiatry (2006) 1.02
Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis. J Biol Chem (1999) 1.02
Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart. J Am Coll Cardiol (1998) 1.02
Monitoring the activation state of the insulin receptor using bioluminescence resonance energy transfer. Mol Pharmacol (2001) 1.02
The effect of testosterone replacement treatment on immunological features of patients with Klinefelter's syndrome. Clin Exp Immunol (2000) 1.01
Changes in intrinsic circular dichroism of several homogeneous anti-type 3 pneumococcal antibodies on binding of a small hapten. Proc Natl Acad Sci U S A (1972) 0.99
Restricted rabbit antibodies: amino acid sequences of rabbit H chains of allotype a1, a2, and a3 in the region 80 to 94. J Immunol (1973) 0.99
In vitro degradation of the C-terminal octapeptide of cholecystokinin by 'enkephalinase A'. FEBS Lett (1983) 0.99
Differential regulation of beta 1- and beta 2-adrenergic receptor protein and mRNA levels by glucocorticoids during 3T3-F442A adipose differentiation. J Biol Chem (1990) 0.99
The biochemical effect of the naturally occurring Trp64-->Arg mutation on human beta3-adrenoceptor activity. Eur J Biochem (1997) 0.98
Anti-idiotype and anti-hormone receptor antibodies. Springer Semin Immunopathol (1983) 0.98
Common ancestor for concanavalin A and lentil lectin? Proc Natl Acad Sci U S A (1978) 0.98
Expression of two human beta-adrenergic receptors in Escherichia coli: functional interaction with two forms of the stimulatory G protein. Proc Natl Acad Sci U S A (1991) 0.98
The amino-terminal sequence of the 40,000 molecular weight subunit of the acetylcholine receptor protein from Torpedo marmorata. FEBS Lett (1979) 0.98
Serological diagnosis of feline immunodeficiency virus infection based on synthetic peptides from Env glycoproteins. Res Virol (1993) 0.97
Woodhouse and Sakati syndrome (MIM 241080): report of a new patient. Clin Dysmorphol (2000) 0.97
Purification of muscarinic acetylcholine receptors by affinity chromatography. EMBO J (1983) 0.97
Characterization and sequencing of a 40-amino-acid peptide from human thyroglobulin inducing experimental autoimmune thyroiditis. J Immunol (1992) 0.97
Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans. Intensive Care Med (1998) 0.97
Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res (2001) 0.97
A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab (2001) 0.96
Multiple amino acid substitutions between murine gamma 2a heavy chain Fc regions of Ig1a and Ig1b allotypic forms. Proc Natl Acad Sci U S A (1981) 0.95
Cellular signaling by an agonist-activated receptor/Gs alpha fusion protein. Proc Natl Acad Sci U S A (1994) 0.95
Transformation by simian virus 40 of spleen cells from a hyperimmune rabbit: evidence for synthesis of immunoglobulin by the transformed cells. Proc Natl Acad Sci U S A (1974) 0.95
Anti-CD3 and phorbol ester induce distinct phosphorylated sites in the SH2 domain of p56lck. J Biol Chem (1993) 0.95
Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase. J Gen Virol (2010) 0.94
Dopamine D4 receptor gene variation impacts self-reported altruism. Mol Psychiatry (2012) 0.94